Aurora kinase inhibitors: a patent review (2014-2020)
Author:
Affiliation:
1. School of Pharmacy, Lanzhou University, Lanzhou, China
Funder
The National Natural Science Foundation of China
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543776.2021.1890027
Reference145 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Cancer statistics, 2020
3. The functional diversity of Aurora kinases: a comprehensive review
4. Aurora kinases: novel therapy targets in cancers
5. The Aurora kinase family in cell division and cancer
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. AURKA Activates FOXO3a to Form a Positive Feedback Loop in the Proliferation and Migration of Keloid Fibroblasts;Advances in Wound Care;2024-08-12
2. Synthesis and antitumor activities of novel 3-(6-aminopyridin-3-yl)benzamide derivatives: Inducing cell cycle arrest and apoptosis via AURKB transcription inhibition;Bioorganic Chemistry;2024-07
3. Knowledge mapping of AURKA in Oncology：An advanced Bibliometric analysis (1998–2023);Heliyon;2024-06
4. Synergy of EGFR and AURKA Inhibitors in KRAS-mutated Non–small Cell Lung Cancers;Cancer Research Communications;2024-05-08
5. A comprehensive review on role of Aurora kinase inhibitors (AKIs) in cancer therapeutics;International Journal of Biological Macromolecules;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3